FIM
MNTA

Freedom Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Freedom Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20,463
Closed -$379K – 1198
2017
Q3 		$379K Buy
+20,463
New +$342K 0.02% 725
2017
Q1 		– Sell
-18,600
Closed -$280K – 1124
2016
Q4 		$280K Sell
18,600
-5,157
-22% -$68.1K 0.02% 726
2016
Q3 		$278K Sell
23,757
-45
-0.2% -$529 0.02% 674
2016
Q2 		$257K Buy
+23,802
New +$246K 0.02% 645

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Freedom Investment Management's MNTA Position: Q4 2017 in Review

Freedom Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2017, closing a stake of 20,463 shares — an estimated $379K sold.

Freedom Investment Management first reported a position in MNTA in Q2 2016 and held it in 4 quarters. The position peaked at $379K in Q3 2017. 166 funds tracked by Wall St. Rank hold MNTA as of Q4 2017.

  • Freedom Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Freedom Investment Management sold 20,463 Momenta Pharmaceuticals, Inc. shares in Q4 2017, an estimated $379K.
  • Freedom Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 4 quarters.
  • Freedom Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $379K in Q3 2017.
  • 166 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2017.

Based on Freedom Investment Management's 13F filing for Q4 2017, filed 25 Jan 2018.